Caseware UK (AP4) 2025.0.111 2025.0.111 2025-10-31 2025-10-31 1 2024-11-01 true No description of principal activity 1 false false 13662549 2024-11-01 2025-10-31 13662549 2023-11-01 2024-10-31 13662549 2025-10-31 13662549 2024-10-31 13662549 c:Director1 2024-11-01 2025-10-31 13662549 c:EntityHasNeverTraded 2024-11-01 2025-10-31 13662549 c:Micro-entities 2024-11-01 2025-10-31 13662549 c:AuditExempt-NoAccountantsReport 2024-11-01 2025-10-31 13662549 c:FullAccounts 2024-11-01 2025-10-31 13662549 c:PrivateLimitedCompanyLtd 2024-11-01 2025-10-31 13662549 d:PoundSterling 2024-11-01 2025-10-31 iso4217:GBP xbrli:pure

Registered number: 13662549 NEWPSOCHEM UK LIMITED UNAUDITED FINANCIAL STATEMENTS INFORMATION FOR FILING WITH THE REGISTRAR FOR THE YEAR ENDED 31 OCTOBER 2025
NEWPSOCHEM UK LIMITED REGISTERED NUMBER: 13662549 BALANCE SHEET AS AT 31 OCTOBER 2025
|  | 2025 |  | 2024
|  | £ |  | £
Current assets | 1 |  | 1 |
Net current assets |  | 1 |  | 1
Net assets |  | 1 |  | 1
Capital and reserves |  | 1 |  | 1
Notes
General information
The company is incorporated in England and Wales as a private company limited by shares. The Registered Office is Hearts of Oak House, 4 Pembroke Road, Sevenoaks, Kent, TN13 1XR.
Average number of employees
The average monthly number of employees, including directors, during the year was 1 (2024 - 1). The Company was entitled to exemption from audit under section 480 of the Companies Act 2006. The members have not required the Company to obtain an audit for the year in question in accordance with section 476 of the Companies Act 2006. The director acknowledges his responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements. These financial statements have been prepared in accordance with the provisions applicable to entities subject to the micro-entities' regime. The financial statements have been delivered in accordance with the provisions applicable to companies subject to the small companies regime. The financial statements were approved and authorised for issue by the board and were signed on its behalf on 27 February 2026.
Ana Navarro
Director
Page 1